Gus Cairns

Gus joined NAM's editorial team in 2009 and previously edited HIV Treatment Update and Preventing HIV. Twitter: @guscairns

HIV vaccine & cure research

The search for an HIV cure

Global health targets

“Zero chance” of meeting goal of ending HIV transmission among UK gay and bisexual men by 2030

Mental & emotional health problems

Suicide rate has fallen in Catalans with HIV – but is still higher than in the general population

PrEP science

PrEP and sexually transmitted infections

Access to healthcare

HIV services in Ukraine resilient but starting to feel the strain

PrEP programmes & uptake

Some women in France are using PrEP, but only transgender women tend to stay on it

Migrants, refugees & displaced people

More than six out of ten migrant gay and bisexual men with HIV in France acquired it there

HIV vaccine & cure research

Cases of HIV cure

The search for a cure

Another class of cancer drugs may contribute to curing HIV

The search for an HIV prevention vaccine

Antibodies that ‘wait and pounce’ generated by promising HIV vaccine candidate

PrEP policies & guidelines

Injectable PrEP requires new testing procedures, IAS conference hears

Starting treatment

Immediate ART associated with fewer deaths in Thailand, but starting a week or two later may lead to less virological failure

Finance & funding

Two modelling studies ask: will injectable PrEP ever be cost-effective at achievable prices?

Retention & linkage to care

At-home support after HIV diagnosis in Uganda helps people get on ART and stick with it

Retention & linkage to care

South Africa: dropping out of HIV care is deadly

Undetectable viral load & treatment as prevention

The amber light: the World Health Organization’s position when an HIV viral load is “suppressed but not undetectable”

The search for a cure

HIV treatment in the womb helped five South African baby boys to stay undetectable off therapy

The search for a cure

Novel drugs that turn HIV against itself might clear infected cells from the body